iShares U.S. Healthcare ETF (IYH)
| Assets | $3.68B |
| Expense Ratio | 0.38% |
| PE Ratio | 22.88 |
| Shares Out | 56.10M |
| Dividend (ttm) | $0.72 |
| Dividend Yield | 1.12% |
| Ex-Dividend Date | Sep 16, 2025 |
| Payout Ratio | 25.52% |
| 1-Year Return | +4.66% |
| Volume | 273,393 |
| Open | 65.30 |
| Previous Close | 65.10 |
| Day's Range | 64.73 - 65.38 |
| 52-Week Low | 53.35 |
| 52-Week High | 66.91 |
| Beta | 0.63 |
| Holdings | 107 |
| Inception Date | Jun 12, 2000 |
About IYH
Fund Home PageThe iShares U.S. Healthcare ETF (IYH) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a cap-weighted index of pharmaceutical, biotechnology, health care services and equipment companies in the US. IYH was launched on Jun 12, 2000 and is issued by BlackRock.
Top 10 Holdings
55.61% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 13.97% |
| Johnson & Johnson | JNJ | 8.37% |
| AbbVie Inc. | ABBV | 6.96% |
| UnitedHealth Group Incorporated | UNH | 5.22% |
| Merck & Co., Inc. | MRK | 4.37% |
| Thermo Fisher Scientific Inc. | TMO | 3.73% |
| Abbott Laboratories | ABT | 3.73% |
| Intuitive Surgical, Inc. | ISRG | 3.49% |
| Amgen Inc. | AMGN | 3.14% |
| Gilead Sciences, Inc. | GILD | 2.62% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 16, 2025 | $0.19284 | Sep 19, 2025 |
| Jun 16, 2025 | $0.16819 | Jun 20, 2025 |
| Mar 18, 2025 | $0.16237 | Mar 21, 2025 |
| Dec 17, 2024 | $0.19952 | Dec 20, 2024 |
| Sep 25, 2024 | $0.23421 | Sep 30, 2024 |
| Jun 11, 2024 | $0.12585 | Jun 17, 2024 |
News
Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discoun...
IYH: Healthcare Dashboard For September
This article provides a top-down view of the healthcare sector based on fundamental metrics. Healthcare providers and pharmaceutical/biotechnology subsectors are undervalued versus 11-year averages. F...
IYH: An Aggressive Positioning On The U.S. Healthcare Industry
IYH is a buy for bullish investors in U.S. healthcare, offering strong exposure to industry leaders benefiting from innovation, aging populations, and digital transformation. The ETF's concentrated po...
IYH: Healthcare Dashboard For April
This article provides a top-down analysis of the healthcare sector, focusing on value, quality and momentum metrics. Current data shows no healthcare subsector is particularly attractive; the least co...
Final Trades: Taiwan Semi, Abbvie, Tradeweb Markets and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...
Final Trades: Vertiv Holdings, Spotify and the IYH
The Investment Committee give you their top stocks to watch for the second half.
IYH: Healthcare Dashboard For January
This article provides fundamental and momentum metrics for healthcare industries. The healthcare sector is currently overvalued by about 12% relative to 11-year averages, with pharmaceuticals/biotechn...
Final Trades: Disney, Ashtead Group, Trade Desk and the IYH
The Investment Committee give you their top stocks to watch for the second half.
IYH: Healthcare Dashboard For October
This monthly report analyzes key industry metrics in the healthcare sector. This sector is overvalued by about 20% relative to 11-year averages. Healthcare providers are the least overvalued subsector...
Final Trades: John Deere, Copart, Amgen and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: KKR & Co, Leidos Holdings, Abbvie, and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Interactive Brokers, Delta, the SMIN and IYH
The Investment Committee give you their top stocks to watch for the second half.
IYH: Strong Performance Expected In The Next Few Years
IYH invests in large-cap U.S. healthcare stocks with strong earnings growth potential. Despite trailing the S&P 500 index in the past year, healthcare stocks are expected to rebound strongly in 2024 a...
IYH: How Another Smaller, Equally-Weighted Competitor May Outperform
iShares U.S. Healthcare ETF is a hold due to high valuations, increased competition, and macroeconomic factors.
Final Trades: JNJ, M, IYH & CLF
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Final Trades: Target, Las Vegas Sands, Apollo Global and the IYH
The Investment Committee share their top stocks in the second half.
Healthcare In 2024: Navigating The Biopharma Bull Run
The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to...
IYH: Good Way To Gain Exposure To The Healthcare Sector
iShares U.S. Healthcare ETF provides exposure to the healthcare sector, holding 120 healthcare-related stocks. Healthcare stocks have had varying performances in recent years, with winners and losers ...
Final Trades: Shake Shack, Pfizer, Humana and iShares US Healthcare
The 'Halftime Report' traders give their top picks to watch for.
Fundamentals for M&A in healthcare sector remain really strong, says Guggenheim's Mehta
Punit Mehta, Guggenheim Securities head of healthcare investment banking, joins 'Squawk on the Street' to discuss the healthcare M&A market, how Mehta sees the growth of the new class of weight-loss d...
IYH: Long-Term Growth Outlook Not As Bright As Before
iShares U.S. Healthcare ETF is not recommended for long-term holding due to diminished long-term earnings growth and rich valuation. IYH has better downside protection than the S&P 500 index and has p...
IYH: Healthcare Dashboard For July
Pharmaceuticals/biotechnology is the most attractive subsector regarding both value and quality scores. Healthcare equipment is the most overpriced healthcare industry. Fast facts on iShares U.S. Heal...